Peptides in pens

Dual-chamber research products. Compare the kit, price and batch documents.

STABILITY STARTS BEFORE ACTIVATION

You are not buying milligrams alone.

What happens to the material before and after preparation matters too.

A high declared content does not automatically mean that the material retains its parameters throughout a research project. Formulation, temperature, light, oxygen exposure, preparation and product-specific stability documentation all matter.

01

Transport

The material remains dry and separated from the liquid until system activation. This limits the time the prepared material spends in solution during storage and delivery.

02

On-site activation

Combination takes place immediately before the research project begins. The preparation time is known, rather than inferred from an unknown period already spent in solution.

03

Post-activation stability

The supplier declares retention of the prepared material's parameters for 90 days at 2–8°C. The declaration requires a stability report specific to the formulation, system and batch.

“Do not ask only how many milligrams a product contains. Ask when it was prepared and how its stability was documented.”
DOCUMENTATION STATUS
Declared period
90 daysSUPPLIER DECLARATION
Post-activation temperature
2–8°CSUPPLIER DECLARATION
Stability report
Document pendingAWAITING VERIFICATION
Batch documentation
Published after verificationAWAITING VERIFICATION

The declared period is not presented as a verified parameter until SUBVERIX™ has reviewed a report for the specific formulation and container.

FIRST INDEPENDENT VERIFICATION PROGRAMME

Retatrutide 40 mg under review.

Once the first batch arrives, sealed samples will be submitted to an independent laboratory in Poland. We will publish the result even if it does not support the supplier's declaration.

01BATCH IN TRANSIT

Batch

We record the batch number, secure unopened samples and assemble the supplier documentation.

02SCOPE DEFINED

Laboratory

We commission LC-MS identity, HPLC purity, actual content and parameters relevant to the lyophilised material.

03AFTER REPORT RECEIPT

Publication

We show the method, chromatograms, result and study limitations - without turning data into a marketing promise.

Trust starts a partnership. Data determine what we publish.The planned quality study does not change the product's intended purpose. The material remains strictly for laboratory research and is not a medicinal product.
REVIEWS FROM THE FIRST ORDERS

Customers value the complete system — not only the product.

Comments have been shortened and edited only for clarity and privacy. Their meaning has been preserved. Individual observations do not guarantee the same result.

Retatrutide 40 mgCUSTOMER REVIEW
“The shipment arrived the next day. Everything was very well protected, and the packaging immediately made a professional impression.”
SUBVERIX customerDelivery and packaging
Lyoprester® + EZnject™CUSTOMER REVIEW
“Connecting the two parts was much easier than expected. The system design makes the process feel intuitive.”
SUBVERIX customerSystem handling
Dual-chamber systemCUSTOMER REVIEW
“What I value most is that the material remains separate from the solvent until activation. The whole format feels considered and convenient.”
SUBVERIX customerTechnology and format